Nisa Investment Advisors
ANRO icon

Nisa Investment Advisors’s Alto Neuroscience ANRO Stock Holding History

Nisa Investment Advisors’s Portfolio ANRO Stock Details ANRO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.92K Hold
338
– – ﹤0.01% 2498
2026
Q1 		$7.6K Hold
338
– – ﹤0.01% 2334
2025
Q4 		$6.02K Hold
338
– – ﹤0.01% 2409
2025
Q3 		$1.36K Sell
338
-78
-19% -$259 ﹤0.01% 2691
2025
Q2 		$915 Buy
416
+175
+73% +$416 ﹤0.01% 2755
2025
Q1 		$521 Buy
+241
New +$862 ﹤0.01% 2784
2024
Q4 		– Sell
-7
Closed -$80 – 3062
2024
Q3 		$80 Buy
+7
New +$86 ﹤0.01% 2920

Other funds holding ANRO

AWG
Alpha Wave Global New York $6.24B AUM 59.73% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $71.3B AUM 56.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SSC
Spruce Street Capital New York $510M AUM
VC
Vivo Capital Palo Alto, California $1.1B AUM 799.93% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
AC
Armistice Capital New York $8.17B AUM 68.82% 1-Year Est. Return

Nisa Investment Advisors's ANRO Position: Q2 2026 in Review

Nisa Investment Advisors held its Alto Neuroscience (ANRO) position steady in Q2 2026 at 338 shares worth $8.92K. The position accounts for ﹤0.01% of the portfolio, ranked #2498.

Nisa Investment Advisors first reported a position in ANRO in Q3 2024 and has held it in 7 quarters since. 114 funds tracked by Wall St. Rank hold ANRO as of Q2 2026.

  • Nisa Investment Advisors held 338 shares of Alto Neuroscience worth $8.92K as of Q2 2026.
  • Nisa Investment Advisors left its Alto Neuroscience share count unchanged in Q2 2026.
  • Alto Neuroscience made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2498 holding.
  • Nisa Investment Advisors first reported a position in Alto Neuroscience in Q3 2024 and has held it in 7 quarters since.
  • 114 funds tracked by Wall St. Rank held Alto Neuroscience as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.